Literature DB >> 30144108

Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis.

Dragos Ciocan1, Cosmin Sebastian Voican1,2, Laura Wrzosek1,2, Cindy Hugot1, Dominique Rainteau3,4,5,6, Lydie Humbert3,4,5, Anne-Marie Cassard1, Gabriel Perlemuter1,2.   

Abstract

BACKGROUND: Intestinal microbiota plays an important role in bile acid homeostasis. AIM: To study the structure of the intestinal microbiota and its function in bile acid homeostasis in alcoholic patients based on the severity of alcoholic liver disease.
METHODS: In this prospective study, we included four groups of active alcoholic patients (N = 108): two noncirrhotic, with (noCir_AH, n = 13) or without alcoholic hepatitis (noCir_noAH, n = 61), and two cirrhotic, with (Cir_sAH, n = 17) or without severe alcoholic hepatitis (Cir_noAH, n = 17). Plasma and faecal bile acid profiles and intestinal microbiota composition were assessed.
RESULTS: Plasma levels of total bile acids (84.6 vs 6.8 μmol/L, P < 0.001) and total ursodeoxycholic acid (1.3 vs 0.3 μmol/L, P = 0.03) were higher in cirrhosis with severe alcoholic hepatitis (Cir_sAH) than Cir_noAH, whereas total faecal (2.4 vs 11.3, P = 0.01) and secondary bile acids (0.7 vs 10.7, P < 0.01) levels were lower. Cir_sAH patients had a different microbiota than Cir_noAH patients: at the phyla level, the abundance of Actinobacteria (9 vs 1%, P = 0.01) was higher and that of Bacteroidetes was lower (25 vs 40%, P = 0.04). Moreover, the microbiota of Cir_sAH patients showed changes in the abundance of genes involved in 15 metabolic pathways, including upregulation of glutathione metabolism, and downregulation of biotin metabolism.
CONCLUSIONS: Patients with Cir_sAH show specific changes of the bile acid pool with a shift towards more hydrophobic and toxic species that may be responsible for the specific microbiota changes. Conversely, the microbiota may also alter the bile acid pool by transforming primary to secondary bile acids, leading to a vicious cycle.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30144108     DOI: 10.1111/apt.14949

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  25 in total

Review 1.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

2.  Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.

Authors:  Ekaterina Smirnova; Puneet Puri; Mark D Muthiah; Kalyani Daitya; Robert Brown; Naga Chalasani; Suthat Liangpunsakul; Vijay H Shah; Kayla Gelow; Mohammed S Siddiqui; Sherry Boyett; Faridoddin Mirshahi; Masoumeh Sikaroodi; Patrick Gillevet; Arun J Sanyal
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

3.  Integrated omics analysis: the relationship between significantly increased Klebsiella post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failure.

Authors:  Yu-Chong Peng; Xin-Hua Zhao; Chuan-Fa Zeng; Jing-Xuan Xu; Lu-Nan Qi; Le-Qun Li
Journal:  J Gastrointest Oncol       Date:  2022-02

Review 4.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

Review 5.  Gut Microbiome and Alcohol-associated Liver Disease.

Authors:  Cyriac A Philips; Bernd Schnabl; Jasmohan S Bajaj
Journal:  J Clin Exp Hepatol       Date:  2022-01-04

Review 6.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

Review 7.  Microbial Products and Metabolites Contributing to Alcohol-Related Liver Disease.

Authors:  Bei Gao; Atoosa Emami; Shilpa Nath; Bernd Schnabl
Journal:  Mol Nutr Food Res       Date:  2020-07-07       Impact factor: 5.914

Review 8.  Role of Gut Microbiota in Hepatocarcinogenesis.

Authors:  Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Ki Tae Suk
Journal:  Microorganisms       Date:  2019-05-05

Review 9.  Role of bile acids in liver diseases mediated by the gut microbiome.

Authors:  Jun-Wei Shao; Tian-Tian Ge; Sen-Zhong Chen; Gang Wang; Qin Yang; Chun-Hong Huang; Li-Chen Xu; Zhi Chen
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

10.  Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis.

Authors:  Bei Gao; Yi Duan; Sonja Lang; Dinesh Barupal; Tsung-Chin Wu; Luis Valdiviez; Bryan Roberts; Ying Yng Choy; Tong Shen; Gregory Byram; Ying Zhang; Sili Fan; Benjamin Wancewicz; Yan Shao; Kevin Vervier; Yanhan Wang; Rongrong Zhou; Lu Jiang; Shilpa Nath; Rohit Loomba; Juan G Abraldes; Ramon Bataller; Xin M Tu; Peter Stärkel; Trevor D Lawley; Oliver Fiehn; Bernd Schnabl
Journal:  Hepatol Commun       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.